News
Another Point for CRISPR: Targeted Treatment Using RNA Editing
A technology with a name more reminiscent of a bag of chips than gene therapy received its first approval for entry into a clinical study last November. The approach, based on RNA editing using the CRISPR-Cas13 technique, will be used to treat age-related macular degeneration. How does the method actually work, and what can we expect from it in the future?
Use of Individualized 3D Printed Models in the Diagnosis and Treatment Planning of Cervical Cancer
3D printing is increasingly gaining importance in various fields of medicine. One of these fields…
Non-Invasive Analysis of Gut Microbiome Biomarkers Enhances Diagnosis of IBD
Recent studies suggest that idiopathic inflammatory bowel diseases (IBD) can affect the composition…
3D Printing in Otology: Printed Grommets Enhance Treatment of Ear Infections
Increasingly precise computational models and new possibilities in 3D printing are gradually making…
Does smoking marijuana increase the risk of head and neck cancers?
Given the extent to which the human population consumes cannabis, it is surprising that its…
New Technology Enables Early Monitoring and Therapy for tPA-Resistant Blood Clots
Resistance of blood clots to treatment with standard intravenous thrombolytics can be a significant…
Non-Invasive Measurement of Intracranial Pressure? Accurate, Finds Johns Hopkins University Team
Intracranial pressure (ICP) is commonly monitored for the management of patients with serious brain…
Can frequent nightmares be a harbinger of dementia?
Nightmares that occur regularly can be more than just an unpleasant experience—they represent a…
How War-Torn Ukraine Became a Breeding Ground for Super-Resistant Bacteria
Cases of sepsis resistant to the most effective antibiotics have been observed in injured soldiers…
New Algorithm to Enhance Prediction of Cardiovascular Disease Risk
A research team from the University of Oxford has developed a new algorithm for predicting the risk…